Every record from Janoshik · page 56
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-019273 | Survodutide | TFC | TFC-2409-Y6260 | 2025-Q1 | 98.66 | 6.32 | 99.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018443 | Semaglutide | WWB | WWB-2501-Y2776 | 2025-Q1 | 99.08 | 3.86 | 88.8 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020549 | MOTS-c | SSA | SSA-2501-M6043 | 2025-Q1 | 97.80 | 3.18 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-018530 | MK-677 (Ibutamoren mesylate) | WWB | WWB-2411-X3830 | 2025-Q1 | 99.93 | 3.00 | 101.6 | Supplier-supplied | 0 | FAIL |
| AX-2025-018416 | Semaglutide | WWB | WWB-2502-W1846 | 2025-Q1 | 99.02 | 6.02 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020039 | BPC-157 | ERP | ERP-2502-P7707 | 2025-Q1 | 99.93 | 4.10 | 107.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020245 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2502-H2314 | 2025-Q1 | 98.18 | 3.79 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-018435 | Semaglutide | WWB | WWB-2501-Y2776 | 2025-Q1 | 99.89 | 4.35 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019143 | Ipamorelin | TFC | TFC-2408-T4425 | 2025-Q1 | 98.81 | 3.78 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-018567 | Retatrutide | WWB | WWB-2412-N4087 | 2025-Q1 | 99.16 | 3.64 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018531 | MK-677 (Ibutamoren mesylate) | WWB | WWB-2411-X3830 | 2025-Q1 | 99.90 | 2.70 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020818 | Semaglutide | SGN | SGN-2410-D9857 | 2025-Q1 | 97.44 | 5.44 | 104.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020532 | Melanotan II | SSA | SSA-2501-N6217 | 2025-Q1 | 99.46 | 5.34 | 94.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020036 | BPC-157 | ERP | ERP-2502-P7707 | 2025-Q1 | 99.93 | 4.08 | 99.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019703 | Tirzepatide | HJ | HJ-2501-P2892 | 2025-Q1 | 98.30 | 2.63 | 98.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018571 | Retatrutide | WWB | WWB-2412-N4087 | 2025-Q1 | 99.19 | 3.57 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-018507 | Semaglutide | WWB | WWB-2501-K3141 | 2025-Q1 | 98.69 | 4.12 | 96.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018474 | Tirzepatide | WWB | WWB-2502-U2990 | 2025-Q1 | 99.34 | 4.08 | 90.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020784 | PT-141 (Bremelanotide) | SGN | SGN-2412-Y9700 | 2025-Q1 | 98.32 | 6.59 | 92.7 | Supplier-supplied | 2 | FAIL |
| AX-2025-020535 | Melanotan II | SSA | SSA-2501-N6217 | 2025-Q1 | 98.73 | 5.06 | 92.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020139 | Enclomiphene citrate | GGPeps | GGPE-2410-S9487 | 2025-Q1 | 97.95 | 4.26 | 105.1 | Supplier-supplied | 1 | FAIL |
| AX-2025-018634 | TB-500 | QYB | QYB-2408-A5127 | 2025-Q1 | 99.45 | 5.31 | 98.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020922 | Thymalin | CPC | CPC-2501-V3057 | 2025-Q1 | N/A | 6.74 | — | Supplier-supplied | 0 | N/A |
| AX-2025-019960 | Melanotan II | SWB | SWB-2411-L5707 | 2025-Q1 | 99.17 | 7.20 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019247 | TB-500 | TFC | TFC-2412-A6202 | 2025-Q1 | 99.93 | 3.41 | 92.3 | Laboratory-retained | 3 | FAIL |
| AX-2025-019244 | TB-500 | TFC | TFC-2412-A6202 | 2025-Q1 | 99.93 | 3.15 | 90.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018770 | TB-500 | QSC | QSC-2411-X7470 | 2025-Q1 | 99.93 | 5.89 | 93.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018655 | Semaglutide | QYB | QYB-2410-V5649 | 2025-Q1 | 99.05 | 3.80 | 93.6 | Supplier-supplied | 0 | PASS |
| AX-2025-018635 | TB-500 | QYB | QYB-2408-A5127 | 2025-Q1 | 99.62 | 4.97 | 89.4 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-021028 | MK-677 (Ibutamoren mesylate) | WXT | WXT-2502-F3530 | 2025-Q1 | 99.36 | 3.90 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020754 | IGF-1 LR3 | SGN | SGN-2409-D9887 | 2025-Q1 | 97.75 | 6.22 | 102.0 | Supplier-supplied | 0 | PASS |
| AX-2025-020666 | L-Glutathione (reduced) | SSA | SSA-2501-W8087 | 2025-Q1 | 98.79 | 10.10 | 106.8 | Laboratory-retained | 0 | PASS |
| AX-2025-019773 | TB-500 | HJ | HJ-2501-A3383 | 2025-Q1 | 98.83 | 4.60 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018426 | Semaglutide | WWB | WWB-2501-S2183 | 2025-Q1 | 99.60 | 3.76 | 92.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020786 | PT-141 (Bremelanotide) | SGN | SGN-2412-Y9700 | 2025-Q1 | 98.53 | 6.50 | 105.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020546 | MOTS-c | SSA | SSA-2501-M6043 | 2025-Q1 | 98.45 | 2.73 | 89.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019709 | Tirzepatide | HJ | HJ-2501-P2892 | 2025-Q1 | 98.72 | 2.26 | 102.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019508 | Humanin (HNG) | Homopeptide | HOMO-2408-A1230 | 2025-Q1 | 99.21 | 5.24 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019057 | KPV | JEEP | JEEP-2410-C3420 | 2025-Q1 | 99.93 | 5.53 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-020929 | Thymalin | CPC | CPC-2501-V3057 | 2025-Q1 | N/A | 6.97 | — | Buyer-sourced | 0 | N/A |